CN Patent

CN101244053A — 以多西他赛为主组分的新的分散体系

Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2008-08-20 · 18y expired

What this patent protects

本发明涉及以多西他赛为主组分的可供注射的分散体系，其由表面活性剂、助表面活性剂和注射用油组成，并且油相与表面活性剂的体积比大于3％小于等于33％。助表面活性剂与表面活性剂的体积比大于等于12.5％小于167％。

USPTO Abstract

本发明涉及以多西他赛为主组分的可供注射的分散体系，其由表面活性剂、助表面活性剂和注射用油组成，并且油相与表面活性剂的体积比大于3％小于等于33％。助表面活性剂与表面活性剂的体积比大于等于12.5％小于167％。

Drugs covered by this patent

Patent Metadata

Patent number
CN101244053A
Jurisdiction
CN
Classification
—
Expires
2008-08-20
Drug substance claim
No
Drug product claim
No
Assignee
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.